Skip to main content

Advertisement

Log in

Metabolic Epilepsy

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Inborn errors of metabolism have been considered as an infrequent cause of epilepsy. Improvement in diagnostics has improved the detection of a metabolic basis of recurrent seizures in neonates and children. The term 'metabolic epilepsy' is used to suggest inherited metabolic disorders with predominant epileptic manifestations as well as those where epilepsy is part of the overall neurological phenotype. Several of these disorders are treatable, and the physician should bear in mind the classical ages of presentation. As there are no specific clinical or electrographic features suggestive of metabolic epilepsies, an early suspicion is based on clinical and laboratory clues. Fortunately, with the advancement of gene sequencing technology, a diagnosis of these rare conditions is more straightforward and may not require invasive procedures such as biopsies, multiple metabolic stress-induced testing for abnormalities, and cerebrospinal fluid analysis. A gene panel may suffice in most cases and can be done from a blood sample. In many countries, many treatable metabolic disorders are now part of the neonatal screen. Early diagnosis and treatment of these disorders can result in the prevention of a full-scale metabolic crisis and improvement of neurological outcomes. Long-term neurological outcomes are variable and additional therapies may be required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Campistol J. Epilepsy in inborn errors of metabolism with therapeutic options. Semin Pediatr Neurol. 2016;23:321–31.

    Article  Google Scholar 

  2. Tumiene B, Peterlin B, Maver A, Utkus A. Contemporary scope of inborn errors of metabolism involving epilepsy or seizures. Metab Brain Dis. 2018;33:1781–6.

    Article  Google Scholar 

  3. van Karnebeek CDM, Sayson B, Lee JJY, et al. Metabolic evaluation of epilepsy: a diagnostic algorithm with focus on treatable conditions. Front Neurol. 2018;9:1016.

    Article  Google Scholar 

  4. Lin Lin Lee V, KarMeng Choo B, Chung YS, P Kundap U, Kumari Y, Shaikh MF. Treatment, therapy and management of metabolic epilepsy: a systematic review. Int J MolSci. 2018;19:871.

  5. Prasad AN, Hoffmann GF. Early onset epilepsy and inherited metabolic disorders: diagnosis and management. Can J Neurol Sci. 2010;37:350–8.

    Article  Google Scholar 

  6. Pascual JM, Campistol J, Gil-Nagel A. Epilepsy in inherited metabolic disorders. Neurologist. 2008;14:S2-14.

    Article  Google Scholar 

  7. Sharma S, Prasad AN. Inborn errors of metabolism and epilepsy: current understanding, diagnosis, and treatment approaches. Int J Mol Sci. 2017;18:1384.

    Article  Google Scholar 

  8. Wolf NI, Garcia-Cazorla A, Hoffmann GF. Epilepsy and inborn errors of metabolism in children. J Inherit Metab Dis. 2009;32:609.

    Article  CAS  Google Scholar 

  9. Rahman S, Footitt EJ, Varadkar S, Clayton PT. Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol. 2013;55:23–36.

    Article  Google Scholar 

  10. van Karnebeek CD, Jaggumantri S. Current treatment and management of pyridoxine-dependent epilepsy. Curr Treat Options Neurol. 2015;17:335.

    PubMed  Google Scholar 

  11. van Karnebeek CD, Stockler-Ipsiroglu S, Jaggumantri S, et al. Lysine-restricted diet as adjunct therapy for pyridoxine-dependent epilepsy: the PDE Consortium Consensus Recommendations. JIMD Rep. 2014;15:1–11.

    Article  Google Scholar 

  12. Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain. 2014;137:1350–60.

    Article  Google Scholar 

  13. Mills PB, Surtees RA, Champion MP, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5’-phosphate oxidase. Hum Mol Genet. 2005;14:1077–86.

  14. Tremino L, Forcada-Nadal A, Rubio V. Insight into vitamin B6 -dependent epilepsy due to PLPBP (previously PROSC) missense mutations. Hum Mutat. 2018;39:1002–13.

    Article  CAS  Google Scholar 

  15. Gallagher RC, Van Hove JL, Scharer G, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol. 2009;65:550–6.

    Article  CAS  Google Scholar 

  16. Pope S, Artuch R, Heales S, Rahman S. Cerebral folate deficiency: analytical tests and differential diagnosis. J Inherit Metab Dis. 2019;42:655–72.

    Article  CAS  Google Scholar 

  17. Wolf B. Biotinidase deficiency: “If you have to have an inherited metabolic disease, this is the one to have.” Genet Med. 2012;14:565–75.

  18. Dhawan SR, Sharawat IK, Saini AG, Suthar R, Attri SV. Diaper rash in an infant with Seizures. J Pediatr. 2019;206:296.

    Article  Google Scholar 

  19. Kasinathan A, Suthar R, Vyas S, Saini AG, Sankhyan N, Attri S. Subacute myelopathy: think beyond neuromyelitis optica spectrum disorder. Ann Indian Acad Neurol. 2019;22:541–2.

    PubMed  PubMed Central  Google Scholar 

  20. Applegarth DA, Toone JR. Glycine encephalopathy (nonketotic hyperglycinaemia): review and update. J Inherit Metab Dis. 2004;27:417–22.

    Article  CAS  Google Scholar 

  21. Van Hove JL, Vande Kerckhove K, Hennermann JB, et al. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis. 2005;28:651–63.

    Article  Google Scholar 

  22. Gramer G, Wolf NI, Vater D, et al. Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood. Neuropediatrics. 2012;43:168–71.

    Article  CAS  Google Scholar 

  23. Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev. 2009;31:545–52.

    Article  Google Scholar 

  24. Sharer JD, Bodamer O, Longo N, Tortorelli S, Wamelink MM, Young S. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:256–63.

    Article  CAS  Google Scholar 

  25. Clark JF, Cecil KM. Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes. Pediatr Res. 2015;77:398–405.

    Article  Google Scholar 

  26. van der Crabben SN, Verhoeven-Duif NM, Brilstra EH, et al. An update on serine deficiency disorders. J Inherit Metab Dis. 2013;36:613–9.

    Article  CAS  Google Scholar 

  27. Dhawan SR, Saini AG, Vyas S, Attri SV. Teaching neuroimages: when MRI is a clue in episodic ataxia. Neurology. 2019;93:e2074–5.

    Article  Google Scholar 

  28. Cosnahan AS, Campbell CT. Inborn errors of metabolism in pediatric epilepsy. J Pediatr Pharmacol Ther. 2019;24:398–405.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

CR: Drafting the manuscript; AGS: Drafting and revising the manuscript. AGS will act as guarantor for this paper.

Corresponding author

Correspondence to Arushi Gahlot Saini.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reddy, C., Saini, A.G. Metabolic Epilepsy. Indian J Pediatr 88, 1025–1032 (2021). https://doi.org/10.1007/s12098-020-03510-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-020-03510-w

Keywords

Navigation